|
Sandoz makes more than 5,000 different doses of generic pharmaceuticals and biotechnological drugs. As the generics arm of Swiss drug firm Novartis AG, Sandoz develops products including antibiotics and hormone therapies, as well as treatments for cancer, cardiovascular, central nervous system, and gastrointestinal disorders. Sandoz produces finished dosage forms of such off-patent drugs as Duragesic (Fentanyl) and Prilosec. It also supplies active pharmaceutical ingredients to other drug makers. Beyond the more common tablet form generics, Sandoz manufactures more complex generics in different delivery systems including injectables, patches, and inhalers. Sandoz sells its products in some 130 countries.
|
| | | Contact Information | |
Address: |
Industriestrasse 25
83607 Holzkirchen, Germany
| | Phone: | +49-8024-476-0 | | Fax: | +49-8024-476-2899 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 0.20 M | | Employees (2008): | 150 |
|
|
Key People
| | • |
CEO:
Andreas Rummelt
| | • |
CFO:
Kevin Plummer
| | • |
Head Technical Operations:
Cesare Frontini
|
|
|
